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United Kingdom
The identification of transcription factor (TF) binding sites in the genome is critical to understanding gene regulatory
networks (GRNs). While ChIP-seq is commonly used to identify TF targets, it requires specific ChIP-grade antibodies
and high cell numbers, often limiting its applicability. DNA adenine methyltransferase identification (DamID), developed
and widely used in Drosophila, is a distinct technology to investigate protein–DNA interactions. Unlike ChIP-seq, it does
not require antibodies, precipitation steps, or chemical protein–DNA crosslinking, but to date it has been seldom used
inmammalian cells due to technical limitations. Here we describe an optimized DamIDmethod coupled with next-generation
sequencing (DamID-seq) in mouse cells and demonstrate the identification of the binding sites of two TFs, POU5F1 (also
known as OCT4) and SOX2, in as few as 1000 embryonic stem cells (ESCs) and neural stem cells (NSCs), respectively.
Furthermore, we have applied this technique in vivo for the first time in mammals. POU5F1 DamID-seq in the gastrulating
mouse embryo at 7.5 d post coitum (dpc) successfully identified multiple POU5F1 binding sites proximal to genes involved in
embryo development, neural tube formation, and mesoderm-cardiac tissue development, consistent with the pivotal role of
this TF in post-implantation embryo. This technology paves the way to unprecedented investigation of TF–DNA interac-
tions and GRNs in specific cell types of limited availability in mammals, including in vivo samples.
[Supplemental material is available for this article.]
Genome-wide transcription factor (TF) occupancy is commonly
assessed by chromatin immunoprecipitation followed by next-
generation sequencing (ChIP-seq), but the need for both ChIP-
grade antibodies and high numbers of cells limits its use (Barski
et al. 2007). Although recent improvements of the ChIP-seq proto-
col, such as the iChIP and the ChIPmentation strategies (Lara-
Astiaso et al. 2014; Schmidl et al. 2015), enabled the detection of
histonemarks across the genome using only 500 cells, they still re-
quire 10,000–500,000 cells to identify targets of the TF SPI1 (also
known as PU.1). The use of CETCh-seq (CRISPR epitope tagging
followed by ChIP-seq) overcomes the need for TF-specific ChIP-
grade antibodies, but it does not reduce the required numbers of
cells (Savic et al. 2015). DNA adeninemethyltransferase identifica-
tion (DamID) is a distinct method to investigate protein–DNA in-
teractions, based on the exogenous expression of a protein of
interest (POI) tethered to the DNA adenine methyltransferase
(Dam) from Escherichia coli (van Steensel et al. 2001). Dam specif-
icallymethylates the adeninewithin a GATC sequence; hence, the
expression of the Dam-POI fusion protein creates unique GAmeTC
marks onDNA adjacent to the POI binding sites. Subsequent geno-
mic DNA (gDNA) extraction, digestion with the GAmeTC-specific
restriction enzyme DpnI, adapter ligation, PCR amplification
and microarray (DamID-chip), or next-generation sequencing
(DamID-seq) allow identification of the POI binding events.
Unlike ChIP-seq, this technique does not require formaldehyde
fixation or immunoprecipitation steps that could lead to data bias-
es (Baranello et al. 2016) or loss of materials. DamID has been used
in seminal studies in Drosophila for over 100 chromatin proteins
and TFs (Moorman et al. 2006; Filion et al. 2010; van Bemmel
et al. 2013). However, only limited success has been reported in
mammalian cells due to technical difficulties. In particular, very
low expression of the Dam protein without tethering POI (Dam-
only) is sufficient to methylate DNA (Wines et al. 1996) since
Dam itself can bind DNA and has highly processive methylation
activity (Urig et al. 2002). The detection of POI-specific binding
sites in DamID depends on the comparison of methylation signa-
tures between Dam-only and Dam-POI–expressing cells. Thus, ex-
pressing Dam-only and Dam-POI at equally low levels in two
independent populations is critical to identify POI-dependent
methylation signals. This issue becomes even more relevant
when the POI interacts with DNA at open chromatin loci (such
as TFs), since Dam-only also preferentially binds and methylates
nucleosome-free DNA (van Steensel et al. 2001). Since the first
mammalian CBX1 DamID-chip paper (Vogel et al. 2006), only a
handful of publications have reported the use of DamID-chip/
seq for TFs in mammalian cells (Supplemental Table S1). We
have overcome the aforementioned difficulties by applying trans-
lation reinitiation–mediated DamID, recently reported in
Drosophila (Southall et al. 2013), to a mouse system. In combina-
tion with Tn5 transposase–mediated tagmentation and next-gen-
eration sequencing, this novel DamID-seq enabled us to detect
clear TF binding signatureswith as little as 1000 cells. Thiswork de-
tails the improvements of the DamID-seq technology and demon-
strates for the first time the identification of in vivo POU5F1
binding sites in the gastrulation-stage mouse embryo.2Present address: Lovely Professional University, Phagwara, Punjab
144411, India
Corresponding author: kkaji@exseed.ed.ac.uk
Article published online before print. Article, supplemental material, and publi-
cation date are at http://www.genome.org/cgi/doi/10.1101/gr.227124.117.
Freely available online through the Genome Research Open Access option.
© 2018 Tosti et al. This article, published in Genome Research, is available un-
der a Creative Commons License (Attribution 4.0 International), as described at
http://creativecommons.org/licenses/by/4.0/.
Method
592 Genome Research 28:592–605 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/18; www.genome.org
www.genome.org
 Cold Spring Harbor Laboratory Press on April 24, 2018 - Published by genome.cshlp.orgDownloaded from 
Results
Development of a translation reinitiation–mediated DamID-seq
in mouse cells
In the original protocol for mammalian DamID-chip, Dam-only
and Dam-CBX1 (formerly HP1β) were expressed via plasmid trans-
fection under the ecdysone-inducible (Ec) promoter (Vogel et al.
2006). The leakiness of this promoter (i.e., in the absence of
ecdysone) was sufficient to achieve an optimal, low expression of
Dam-only/POI, and this strategy has been used for many DamID
experiments in Drosophila Kc cells (Filion et al. 2010; van
Bemmel et al. 2013). However, this approach limits the applicabil-
ity of DamID where efficient transfection/viral infection or propa-
gation of transfected cells is possible. In addition, expression levels
of Dam-only/POI depend on transfection/infection efficiency, in-
tegration copynumbers, and integration sites; hence, achieving an
equal expression level in two independent samples is technically
challenging. Recently, the phenomenon of translation reinitiation
has been exploited in Drosophila to achieve an optimal Dam ex-
pression level in a tissue-specific manner in combination with
the GAL4-UAS system (Southall et al. 2013). Translation reinitia-
tion takes place as the eukaryotic ribosome does not always detach
from mRNA at the stop codon of a first open reading frame (ORF)
and can restart translation of a second downstream ORF.
Expression level of the protein encoded by the second ORF de-
creases as the length of the first ORF increases (Kozak 2001), pro-
viding a method by which to fine tune the level of Dam-only/
POI expression (Southall et al. 2013).
To optimize translation reinitiation–mediated DamID in
mammalian systems, we initially focused on the binding of the
master regulator of pluripotency, POU5F1, in mouse embryonic
stemcells (ESCs). PrecedingDamID experiments, the functionality
of the Dam-POU5F1 fusion protein was confirmed bymaintaining
an undifferentiated state in an inducible Pou5f1 knockout ESC line
(Supplemental Fig. S1).
We then generated an ESC line containing a PhiC31 inte-
grase–mediated cassette exchange platform within the Gt(ROSA)
26Sor locus (Fig. 1A), allowing us to generate various cell lines
with Dam-only/POI expression under the endogenous Gt(ROSA)
26Sor promoter with high (∼100%) efficiency via simple plasmid
transfection and drug selection.
To identify the optimal length of the first ORF for translation
reinitiation–mediated DamID, we placed the dam-only/dam-
Pou5f1 coding sequences downstream from the stop codon of
three different ORFs: blasticidin- (Bsd, 393 bp), neomycin- (Neo,
804 bp), and hygromycin- (Hyg, 1032 bp) resistance cassettes
(Supplemental Fig. S2). Then we measured the methylation level
at the Pou5f1 locus in each cell line by quantitative PCR (qPCR)–
based DamID (qDamID) (Supplemental Fig. S2; Methods).
When the Bsd cassette was used, the Dam-only methylation
level at many of the tested DNA loci was >70%, indicating that
Dam expression was too high, although POU5F1 binding was ob-
served at the previously described target site O4 (Supplemental Fig.
S2A). The use of Neo cassette successfully decreased the methyla-
tion levels, generating a POU5F1 binding signature similar to
ChIP-seq data (Supplemental Fig. S2A). The longer ORF Hyg cas-
sette made the methylation signals even lower and the overall sig-
nals indistinguishable between Dam-only and Dam-POU5F1–
expressing cell lines. Thus, we opted to use the Neo cassette as
the first ORF, and these cell lines were referred to as Rosa26-Neo-
Dam and Rosa26-Neo-Dam-Pou5f1 ESC lines in the subsequent
experiments.
Translation reinitiation–mediated DamID enables the detection
of TF binding dynamics during ESC differentiation
One of the big advantages of generating Dam-only/POI–express-
ing ESC lines is that they can be differentiated into any cell type.
The Rosa26-Neo-Dam and Rosa26-Neo-Dam-Pou5f1 ESC lines
differentiated similarly well into epiblast-like cells (EpiLCs)
(Supplemental Fig. S3A) and into fibroblast-like cells in vitro.
Since the protein level of Dam-only/POI via translation reinitia-
tion is extremely low, it is unlikely to affect the functionality of
the cells. Neo-Dam and Neo-Dam-Pou5f1 mRNA levels remained
constant after differentiation as we used the ubiquitously active
endogenous Gt(ROSA)26Sor promoter (Supplemental Fig. S3A,B).
In contrast, when we placed the Ec promoter-driven Dam-only/
Pou5f1 cassettes in the Gt(ROSA)26Sor locus, the transgenes
were silenced following differentiation into fibroblast-like cells
(Supplemental Fig. S3C). Although the Rosa26-Neo-Dam and
Rosa26-Neo-Dam-Pou5f1 lines constitutively express Dam-only/
Dam-POU5F1, we observed loss and gain of the POU5F1 binding
signatures using a 72-h EpiLC differentiation protocol (Supple-
mental Fig. S3D), in agreement with ChIP-seq data. In summary,
these results indicated that the translation reinitiation–based
DamID system could detect distinct POI binding signal in different
cell types, as long as cells divide and dilute the methylation signal
generated in previous differentiation stages.
Optimization of DamID-seq protocol
A few studies have described the use of DamID-seq for the analysis
of TF binding in mammalian cells (Supplemental Table S1), yet
with little modifications of the original DamID-chip protocol
(Vogel et al. 2007). Thus, we revisited each step of the protocol
and optimized it for DamID-seq (Fig. 1B). gDNA was extracted us-
ing the Quick-gDNA MicroPrep kit (Zymo Research) and then di-
gested with DpnI, which specifically cuts GAmeTC sequences.
Following adapter ligation, DNA was digested with DpnII (which
specifically cuts nonmethylated GATC sites) before adapter-medi-
ated PCR amplification. The DpnII digestion step was described in
the original protocol to avoid amplification of large fragments that
do not contain Dam/Dam-POI–bound sites but are flanked by the
DpnI-digestedGAmeTC sites. Although this step has been excluded
in recent protocols (Bouveret et al. 2015; Jacinto et al. 2015; Kind
et al. 2015), we found that the intensity of theDam-POU5F1 signal
over the Dam-only control was reduced without this DpnII diges-
tion step (Supplemental Fig. S4A). POU5F1 DamID has been re-
cently used to validate a DamID-seq protocol in a different study
(Jacinto et al. 2015). The data from Jacinto et al. (2015) presented
lower signal-to-noise ratio compared to our data, maybe due to the
lack of DpnII digestion step before PCR amplification in their pro-
tocol and/or potentially due to the difficulty in achieving optimal
expression levels of Dam-only/Pou5f1 using viral transduction
(Supplemental Fig. S5).
For the amplification of the adapter-ligated DNA fragments,
we found that the KAPAHiFi polymerase provided a better genome
coverage than Advantage2 polymerase previously used (Supple-
mental Fig. S4B; van Steensel et al. 2001; Guelen et al. 2008; Sou-
thall et al. 2013).We also introduced a qPCR step to determine the
optimal number of PCR cycles for the fragment amplification in
order to minimize amplification biases (Supplemental Fig. S4C).
All these steps could be performed in a single tube, and the ampli-
fied DNA was then purified using SPRI magnetic beads. The
purified Dam-only/POI target DNAwas subjected to library prepa-
ration for Illumina sequencingwith Tn5 transposition (Picelli et al.
Mammalian DamID-seq with 1000 cells and in vivo
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Figure 1. Optimization of DamID-seq in mouse embryonic stem cells (ESCs) and comparison with ChIP-seq. (A) ϕC31 integrase–mediated cassette ex-
change system used to generate the cell lines in this study. (POI) Protein of interest; (ORF) open reading frame. (B) The optimized DamID-seq workflow.
(C ) POU5F1 DamID-seq tracks generated from 106 ESCs and POU5F1 ChIP-seq tracks generated from 107 ESCs (Buecker et al. 2014). The bars below
each track represent ChIP-seq (black) and DamID-seq (blue) statistically significant peaks; y-axis represents read counts per million of Dam-POU5F1
(Dam-subtracted) and POU5F1 ChIP-seq (input-subtracted), respectively. (D) Peak overlap between three different published POU5F1 ChIP-seq data sets
(Marson et al. 2008; Whyte et al. 2013; Buecker et al. 2014). (E) Overlap between POU5F1 DamID-seq peaks and the union of ChIP-seq peaks. Since
DamID-seqpeaks are larger thanChIP-seqpeaks (see Supplemental Fig. S6B) andcan containmultipleChIP-seqpeakswithin, thenumberof theoverlapping
peaks are shown separately for each technology. (F )Motif enrichment analysis (Heinz et al. 2010) of the POU5F1-boundpeaks identified only byDamID-seq,
ChIP-seq, or both technologies. (G)Geneontology (GO) enrichment analysis of POU5F1peaks identifiedonly byDamID-seq,ChIP-seq, or both usingGREAT
(McLean et al. 2010).
Tosti et al.
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2014), which allowed us to fragment the DNA to the desired size
range (∼250–350 bp) for NGS and to introduce Illumina sequenc-
ing–compatible ends in a 5-min reaction. This DamID-seq proto-
col (from gDNA extraction to NGS library preparation) can be
accomplished in ∼3 d.
POU5F1 DamID-seq with 106 ESCs and comparison with ChIP-seq
We initially performed POU5F1 DamID-seq using 106 ESCs. Visual
inspection of the POU5F1DamID-seq tracks, generated by subtrac-
tion of the Dam-only signal from the Dam-POU5F1 signal, re-
vealed good agreement with POU5F1 ChIP-seq data generated
with 107 ESCs (Fig. 1C). We reanalyzed three previously published
POU5F1 ChIP-seq data sets (Fig. 1D; Marson et al. 2008; Whyte
et al. 2013; Buecker et al. 2014) and used the union of the identi-
fied peaks (51,122 in total) for further comparison with the
35,311 POU5F1 DamID-seq peaks identified in this study using a
new DamID-seq data analysis pipeline described in the Methods
(the source code is available in Supplemental Material S1). About
40% of the POU5F1 DamID-seq peaks overlapped with 35% of
the POU5F1 ChIP-seq peaks (Fig. 1E). This overlap was larger
than that between standard formaldehyde-crosslinked ChIP-seq
and recently published UV laser–crosslinked ChIP-seq using the
same antibody (Steube et al. 2017). Motif enrichment analysis
confirmed the enrichment of the POU5F1 motif in the overlap-
ping peaks, as well as in DamID-specific and in ChIP-specific peaks
(Fig. 1F). Overall, a substantial number of peaks contained the
POU5F1 motif, specifically: ∼67% of the DamID-seq peaks and
∼30% of the ChIP-seq peaks (Supplemental Fig. S6A,B). However,
both peak size and location of themotif within each peakwere dis-
tinct between DamID-seq and ChIP-seq (Supplemental Fig. S6C,
D). The mode of DamID-seq peak size was 1143 bp (Supplemental
Fig. S6C), and the distribution of POU5F1motif was widely spread
across ±2 kb from the peak center (Supplemental Fig. S6D). The
mode of ChIP-seq peak size was 334 bp with the POU5F1 motif
in the center of the peak (Supplemental Fig. S6C,D).Whenwe ran-
domly selected the same numbers of genomic regions while main-
taining the same size distribution as DamID-seq or ChIP-seq peaks,
we found that∼53%and∼15%of these random regions contained
the POU5F1 motif, respectively (Supplemental Fig. S6A,B). Hence,
we concluded that the higher presence of the POU5F1 motif in
DamID-seq peaks was due to their bigger size compared with
ChIP-seq peaks and that both technologies can enrich for genomic
regions containing the POU5F1 motif.
Interestingly, DamID-specific peaks were highly enriched
with SOX2 and KLF5 motifs, instead of the POU5F1-SOX2-TCF-
NANOG binding motif enriched in the overlapping and ChIP-
seq–specific peaks (Fig. 1F). POU5F1 and SOX2 bind synergistically
to theOCT/SOXmotif with higher affinity (Ambrosetti et al. 1997;
Mistri et al. 2015), while other pluripotency genes co-occupy their
targets without such a known synergistic effect. Since DamID can
detect transient or weak protein–DNA interaction (Aughey and
Southall 2016), DamID-specific peaks may reflect the sensitive na-
ture of this technology. When we performed Gene Ontology (GO)
enrichment analysis using GREAT (McLean et al. 2010), GO terms
associated with the overlapping peaks included “stem cell mainte-
nance,” “blastocyst formation,” and “neural tube formation” (Fig.
1G) in agreement with known POU5F1 function in mESCs and in
embryonic development (Niwa et al. 2000; Simandi et al. 2016).
On the contrary, POU5F1 DamID-seq– and ChIP-seq–specific
peaks were associated with GO terms not related to previously de-
scribed POU5F1 functions.
When we investigated the features of DamID/ChIP-seq–spe-
cific peaks, we found that ChIP-specific peaks were nucleosome-
free (measured by DNase-seq), similar to the overlapping peaks,
but they showed higher levels of H3K4me3 and, to a lesser extent,
H3K27me3 and H3K4me1 (Fig. 2A). Conversely, DamID-seq–spe-
cific peaks were not nucleosome-free, with very lowDam-only sig-
nal consistent with the fact that Dam-only preferentially binds to
nucleosome-free DNA. Higher Dam-POU5F1 signal in those loci
potentially reflects the pioneering activity of POU5F1 (Fig. 2A;
Soufi et al. 2015). DamID-seq–specific peaks were not enriched
with any of these active histone modifications or repressive
H3K27me3mark (Fig. 2A). Instead, they showed∼75%CpGmeth-
ylation, while the ChIP-seq–specific peaks had only ∼25% CpG
methylation (Fig. 2B). Consistent with these features, only ∼10%
of the DamID-specific peaks, but ∼30% of the ChIP-specific peaks
were located in the gene promoters (Fig. 2C). The genes containing
DamID-seq peaks in the promoter were expressed at lower levels
than those containing ChIP-seq peaks (Fig. 2D). About 15% and
18% of those genes were up- or down-regulated (FDR < 0.05)
24 h after termination of Pou5f1 expression (King and Klose
2017), while >26% of the genes with overlapping peaks in the pro-
moter regions changed their expression (Fig. 2E). The features of
ChIP-seq–specific peaks (enrichment of H3K4me3, close proximi-
ty to TSS, low CpG methylation, high expression of target genes)
resembles the regions described as “hyper-ChIPable” or “phantom
peaks” in yeast and in fly (Park et al. 2013; Teytelman et al. 2013;
Jain et al. 2015) and, more recently, as “HOT regions” in worm,
mouse, and human ChIP-seq data (Wreczycka et al. 2017).
Notably, ∼51% of the mouse HOT regions overlapped with
POU5F1 ChIP-seq–specific peaks, while only ∼3% of them over-
lapped with POU5F1 DamID-specific peaks (Fig. 2F). Since Dam-
only tends to methylate open loci, the comparison between
Dam-only and Dam-POU5F1 samples in DamID-seq is likely to ex-
clude the HOT regions from the peak list, while some of the ChIP-
seq–specific peaks could represent true POU5F1 binding sites not
identified by DamID-seq.
SOX2 DamID-seq with 106 NSCs and comparison with ChIP-seq
To confirm our observations about the features of DamID-seq data
in different cell types and different TFs, we performed SOX2
DamID-seq in mouse NSCs differentiated in vitro from Rosa26-
Neo-Dam and Rosa26-Neo-Dam-Sox2 ESC lines. For the comparison
with the 106 NSC DamID-seq data, we used the union of two pub-
lished NSC SOX2 ChIP-seq data (Fig. 3A; Mateo et al. 2015; Mistri
et al. 2015). Similar to the ESC POU5F1DamID-seq/ChIP-seq com-
parison, ∼44% of SOX2 NSC DamID-seq peaks overlapped with
∼30% of ChIP-seq peaks (Fig. 3B). These overlapping peaks as
well as DamID-seq/ChIP-seq–specific peaks showed enrichment
of the SOX2 motif and NSC-related GO terms following GREAT
analysis (Fig. 3C,D). Percentages of peaks with the SOX2 motif,
peak size distribution and motif position were similar to what we
observed in POU5F1 DamID-seq and ChIP-seq in ESCs (Supple-
mental Fig. S7). Similarly, the SOX2 DamID-seq–specific peaks
were also devoid of signals from DNase-seq and from H3K4me3
and H3K27me3 ChIP-seq, and the SOX2 ChIP-seq–specific peaks
had stronger DNase-seq and H3K4me3 ChIP-seq signals (Fig. 3E).
Furthermore, NSC SOX2 ChIP-seq–specific peaks also had the
highest proportion (∼25%) of peaks in the promoter regions, in-
cluding ∼37% of mouse HOT regions (Fig. 3F,G).
In summary, we have shown that TF DamID-seq with about
10-fold fewer cells (106 cells) can identify POU5F1 and SOX2
Mammalian DamID-seq with 1000 cells and in vivo
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Figure 2. Characterization of POU5F1 DamID-seq and ChIP-seq peaks. (A) For each POU5F1 DamID/ChIP-seq overlapping and specific peaks, the signal
intensities from POU5F1 DamID-seq (Dam; Dam-POU5F1 separately), POU5F1 ChIP-seq, DNase-seq, and H3K4me3, H3K4me1, H3K27Ac, and
H3K27me3 ChIP-seq are represented. (B) CpGmethylation levels of POU5F1 DamID/ChIP-seq overlapping and specific peaks. The ChIP-seq–specific peaks
were extended to the same average size of DamID-seq peaks as to avoid biases due to different size of the peaks. (C) Distribution of POU5F1 DamID/ChIP-
seq overlapping and specific peaks in the genome. (D) Expression level of genes with DamID-seq–specific (384 genes), overlapping (739 genes), and ChIP-
seq–specific peaks (2372 genes) in their promoter regions (±3 kb from TSS). (E) Expression changes of genes in D, 24 h after knockdown of Pou5f1 in ESCs
(King and Klose 2017). (F ) DamID/ChIP-seq overlapping and specific peaks including mouse ChIP-seq HOT regions (Wreczycka et al. 2017).
Tosti et al.
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Figure 3. 106 NSC SOX2 DamID-seq in comparison with ChIP-seq. (A,B) Union of two published NSC SOX2 ChIP-seq data sets (A) (Mateo et al. 2015;
Mistri et al. 2015) and its overlap with 106 NSC SOX2 DamID-seq peaks (B). (C ) Motif enrichment analysis (Heinz et al. 2010) of the SOX2-bound peaks
identified only by DamID-seq, ChIP-seq, or both technologies. (D) GO enrichment analysis of SOX2 peaks identified only by DamID-seq, ChIP-seq, or both
using GREAT (McLean et al. 2010). (E) For each SOX2 DamID/ChIP-seq overlapping and specific peaks, the signal intensities from SOX2 DamID-seq (Dam;
Dam-SOX2 separately), SOX2 ChIP-seq, DNase-seq, and H3K4me3 and H3K27me3 ChIP-seq are represented. (F ) Distribution of SOX2 DamID/ChIP-seq
overlapping and specific peaks in the genome. (G) DamID/ChIP-seq overlapping and specific peaks including mouse ChIP-seq HOT regions (Wreczycka
et al. 2017).
Mammalian DamID-seq with 1000 cells and in vivo
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targets in ESCs and NSCs, respectively, of which 40%–44% were
also identified by ChIP-seq. Considering the fundamental differ-
ences between the two techniques, as well as the scarcity of strate-
gies to validate ChIP-seq data, this reproducible overlap rate in two
different TFs and cell types is encouraging. Importantly, the over-
lap between ESC POU5F1 DamID-seq and NSC SOX2 DamID-seq
peaks was as small as that between ESC POU5F1 ChIP-seq and
NSC SOX2 ChIP-seq peaks (Supplemental Fig. S8), indicating
that the technique-dependent nonspecific peaks in DamID-seq
are as few as those in ChIP-seq. A number of nonoverlapping peaks
with distinct features exist in both techniques, and their function-
al importance needs to be carefully studied in future. Nevertheless,
the overlapping peaks have stronger signals in both DamID-seq
and ChIP-seq (Figs. 2A, 3E; Supplemental Fig. S9). Hence, a possi-
ble strategy to reduce the technique specific peaks and enrich
peaks that can be identified by both DamID-seq and ChIP-seq
would be increasing the threshold of the peak calling.
TF DamID-seq in 1000 flow-sorted ESCs and NSCs
Since the DamID protocol does not include any precipitation pro-
cedure, which causes a loss of DNA, we reasoned that it could be
applied to lower numbers of cells. Accordingly, we performed
POU5F1 DamID-seq with 104 and 103 Rosa26-Neo-Dam and
Rosa26-Neo-Dam-Pou5f1 ESCs (Fig. 4A). While the number of stat-
istically significant POU5F1 peaks decreases when using fewer
cells, the peaks highly overlap with those identified from 106
ESCs (Fig. 4B). Peaks identified from 104 and 103 cells correspond
to thosewith a higher number of reads in 106 ESCDamID-seq (Fig.
4C), and they overlappedwith∼80% and∼60%ofmESC super en-
hancers (Whyte et al. 2013), respectively (Fig. 4D). The POU5F1-
SOX2 motif and gene ontologies related to known POU5F1 func-
tions (“stem cell maintenance,” “neural tube closure”) were en-
riched in 103 ESC POU5F1 DamID-seq (Fig. 4E,F). Similarly
SOX2 DamID-seq peaks identified in 104 and 103 NSCs highly
overlapped with those in 106 NSCs (Fig. 4G,H). The SOX2 motifs
and NSC-related Gene Ontologies (“hindbrain development,”
“neuronal stem cell maintenance”) were enriched in 103 NSC
SOX2 DamID-seq (Fig. 4I,J). In agreement with the fact that peaks
from 104 and 103 cells overlap with stronger peaks in 106-cell
DamID-seq, a higher proportion of 104- and 103-cell DamID-seq
peaks overlapped with ChIP-seq peaks (Supplemental Fig. S10A,
B). Consistently, DamID-seq peaks from 104 and 103 are enriched
in the overlapping peaks between 106 DamID-seq and ChIP-seq
peaks (Supplemental Fig. S10C,D). Thus, even when using lower
cell numbers, DamID-seq specifically identifies the most robust
binding sites, likely representing functionally relevant TF-genome
engagement events. Overall, these data indicate the wide applica-
bility of DamID-seq across different cell types and TFs, even when
the starting cell number is limited. To our knowledge, these data
represent the lowest number of cells used for the identification
of TF binding sites in mammalian cells.
POU5F1 DamID-seq in vivo
Next, we performed in vivo POU5F1DamID-seq using∼7.5 d post-
coitum (dpc) embryos containing approximately 15,000 cells
(Snow 1977; Tzouanacou et al. 2009), where endogenous
POU5F1 is ubiquitously expressed (Rosner et al. 1990; Peng et al.
2016), by generating chimeric embryos with Rosa26-Neo-Dam
and Rosa26-Neo-Dam-Pou5f1 ESCs (Fig. 5A).
Each embryo showed a different level of ESC contribution as
observed by the amount of Nanog-GFP reporter–positive ESC-de-
rived cells in the posterior region of the embryos. The differentia-
tion into multiple cell types within each embryo could further
reduce the consistency of POU5F1 binding sites in the bulk sam-
ples. Accordingly, the in vivo DamID-seq data showed a higher
variability between replicates compared with the POU5F1 ESC
and SOX2 NSC data (Supplemental Fig. S11). Despite this variabil-
ity, we identified 2768 peaks, which consistently had higher reads
counts in six Dam-POU5F1–expressing embryos compared to six
Dam-expressing embryos (FDR < 0.1), as seen for the 7356 peak re-
gions identified in 1000 ESCs POU5F1 DamID-seq using four rep-
licates each for Dam and Dam-POU5F1 (Supplemental Fig. S12).
We performed further analyses with the 343 high-confidence
peaks with a high signal and lower variability among those 2768
peaks (Fig. 5B,C) and found the POU5F1motif andGO terms relat-
ed to early embryo development were highly enriched in those
peaks and peak-associated genes, respectively (Fig. 6A,B).
Of the 94 ‘early embryo development’ peak-associated genes,
many were highly expressed in EpiSCs, the in vitro counterpart of
the 6- to 7.5-dpc epiblast (Tesar et al. 2007), rather than in ESCs
(Fig. 6C). Consistently, in vivo transcriptome data (Kojima et al.
2014) demonstrated that most of these genes were up-regulated
at post-implantation stages, in particular at the early bud (EB)
and late bud (LB) stages (∼7.5 dpc) (green bar in Fig. 6D;
Supplemental Table S2). It is noteworthy that the expression levels
of the peak-associated genes, Mycn, Hand2, Prickle2, Sox4, Prrx1,
and Nr2f2, changed approximately twofold 24 h after deletion of
Pou5f1 at ∼7.5 dpc using the Cre-loxP system (Fig. 6E,F; DeVeale
et al. 2013). Thus, POU5F1 binding signatures identified by
DamID-seq provide a valuable resource to elucidate how POU5F1
controls the expression of genes critical for embryo development
(Osorno et al. 2012; DeVeale et al. 2013; Aires et al. 2016).
Overall, we optimized a powerful technique to identify TF–
DNA interactions, DamID-seq, for mammalian cells and estab-
lished it as a unique strategy to identify TF binding sites in limited
numbers of cells including in vivo samples.
Discussion
In this work, we have described an optimized DamID-seq for TF
target identification in mouse cells by combining the use of the
ubiquitously active endogenous Gt(ROSA)26Sor promoter with
translation reinitiation. This approach has enabled us to detect
TF targets in as few as 1000 cells and in developingmouse embryos
at the gastrulation stage. The applicability of TF DamID-seq to
much smaller cell numbers opens opportunities for new investiga-
tions in various biological contexts, even though the spatial reso-
lution of DamID-seq is lower than ChIP-seq as the signal relies on
the frequency of the GATC sequences (∼260 bp on average in the
mouse genome). To date, ChIP-seq has been almost the only strat-
egy used to uncover TF targets in a genome-wide manner in mam-
malian cells. Although several technical advances have beenmade
(Furey 2012; Lara-Astiaso et al. 2014; Savic et al. 2015; Schmidl
et al. 2015), TF ChIP-seq with more than 10,000 cells has not
been reported.
Dam-POU5F1/Dam-SOX2 fusion proteins were expressed
at extremely low levels using translation reinitiation, yet they la-
beled the binding sites of POU5F1 and SOX2, competing with
these endogenously highly expressed TFs in ESCs and NSCs, re-
spectively. Themajority of stronger ChIP-seq peaks, which are sup-
posed to have strong/more frequent binding of endogenous TFs,
were identified by DamID-seq (Supplemental Fig. S9). Therefore,
it is unlikely that the competition between lowly expressed
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Figure 4. 104, 103 ESC POU5F1 DamID-seq and 104, 103 NSC SOX2 DamID-seq. (A) POU5F1 DamID-seq tracks from 106/104/103 ESCs and POU5F1
ChIP-seq track from 107 ESCs (Buecker et al. 2014). (B) Overlaps of 106/104/103 ESC POU5F1 DamID-seq peaks. (C) Read counts of peaks in 106 ESC
DamID-seq (blue) and those identified by 104 (gray) and 103 (green) ESC DamID-seq. (D) Percentage of ESC super enhancers (Whyte et al. 2013) contain-
ing POU5F1 DamID-seq peaks using different number of cells. (E) Motif enrichment in the 103 ESC POU5F1 DamID-seq peaks. (F ) GO enrichment analysis
of 103 ESC POU5F1 DamID-seq peaks using GREAT (McLean et al. 2010) (G) SOX2 DamID-seq tracks from 106/104/103 NSCs and SOX2 ChIP-seq tracks
generated from 5 × 106 NSCs (Mateo et al. 2015). (H) Overlaps of 106/104/103 NSC SOX2 DamID-seq peaks. (I) Motif enrichment in the 103 NSC SOX2
DamID-seq peaks. (J) GO enrichment analysis of SOX2 DamID-seq peaks from 103 NSCs.
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exogenous Dam-POI and highly expressed endogenous POI com-
promises the identification of POI binding sites. In fact, DamID
has been proven to be a powerful tool in Drosophila to uncover
the binding sites of approximately 100 different chromatin pro-
teins (Filion et al. 2010; van Bemmel et al. 2013), suggesting that
this mouse translation-reinitiation DamID-seq can be applied to
various TFs in different cell types in vitro and in vivo.
DamID has predominantly been used to investigate chroma-
tin proteins (Filion et al. 2010; van Bemmel et al. 2013). For closed
chromatin binding proteins, it is relatively straightforward to
identify POI-specific binding because the background (Dam-
only) signal is low, due to Dam’s infrequent access to closed
chromatin (Kladde and Simpson 1994). The first successful
DamID experiments in human cells were performed for hetero-
chromatin binding protein CBX1 and LMNB1 (Vogel et al. 2006;
Guelen et al. 2008). More recently, DamID-seq has been used to
investigate LMNB1 binding even in single human cells (Kind
et al. 2015). In contrast, TF DamID has been more technically
challenging since Dam-only frequently methylates GATC at
open chromatin loci, resulting in high background methylation
signal. In addition, TF binding sites are much narrower (8–20 bp)
compared with lamina-associated domains (LADs; median size
∼0.5 Mb). Therefore, the number of DNA fragments obtained
from one binding domain/site following DpnI digestion is much
lower. This makes the DamID-seq peak calling step more difficult,
which is based on the statistical comparison between Dam-only
and Dam-TF–expressing cells. A limitation of DamID-seq is the
requirement of the exogenous expression of Dam/Dam-POI.
However, the PhiC31 RMCE system we have developed allows
the generation of Dam-POI ESC lines via simple plasmid transfec-
tion. The resulting ESCs can be used to generate chimeric mice or
mouse lines, making DamID-seq possible with any tissue of the
mouse embryo since the Gt(ROSA)26Sor promoter is ubiquitously
active.
Despite the constitutive expression of Dam/Dam-POU5F1,
we could successfully detect gain and loss of TF binding signatures
during cell differentiation since the methylation signal was most
likely diluted through cell division. When investigating TF bind-
ing dynamics in post-mitotic cells or slowly dividing cells, a limi-
tation of our DamID-seq system is the lack of inducibility of
Dam-only/POI protein. A tightly regulated inducible tissue-specif-
ic Dam-only/POI protein expression system in adult mouse would
further increase the applicability of DamID-seq in vivo (Southall
et al. 2013; Pindyurin et al. 2016). Another important develop-
ment of TF DamID-seq would be its application in human cells,
in which so far DamID has been usedmainly for closed chromatin
A
B
C
Figure 5. POU5F1 DamID-seq with 7.5-dpc epiblasts. (A) DamID-seq samples were prepared from each Dam/Dam-POU5F1–expressing 7.5-dpc chime-
ric embryo generated via morula aggregation, excluding the PGC-containing region.Nanog-GFP confirms contribution of Dam/Dam-POU5F1 ESCs, while
the reporter expression is limited to posterior. (B) Read counts and coefficient of variation of the epiblast POU5F1 DamID-seq peaks. Peaks with high read
counts (log2 > 4.5) and low standard deviation (<75%) indicated in red were used for further analyses. (C) The merged epiblast POU5F1 DamID-seq tracks
(top) generated from six Rosa26-Neo-Dam-Pou5f1 and six Rosa26-Neo-Dam embryos. Blue bars indicate selected confident peaks from B.
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binding proteins by exploiting the leakiness of Ec promoter to ex-
press Dam/Dam-POI following viral delivery of the transgenes. In
order to achieve a more controlled expression of Dam/Dam-POI
and successful TF DamID-seq, human ES/iPS cell lines with the
translation reinitiation system in a safe ubiquitously expressed lo-
cus (such as the AAVS1) could be established. Obtaining a large
numbers of desired cell types in human ES/iPS cell differentiation
is often difficult; thus, DamID-seq could have a large advantage
over ChIP-seq in many experimental settings.
About 35% of POU5F1 peaks identified in three different
ChIP-seq data sets were also identified by DamID-seq using a 10-
fold lower number of mESCs. This overlap is substantial consider-
ing the intrinsic differences of the two techniques, the distinct
data analysis methods, the variety of cell culture conditions, and
the fact that the overlap between ChIP-seq data sets themselves
is also limited. The features of DamID-seq–specific peaks were rem-
iniscent of so-called “null” or “inert” chromatin previously de-
scribed in Drosophila melanogaster (Filion et al. 2010; Kharchenko
A
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Figure 6. Analysis of POU5F1 target genes in the 7.5-dpc epiblasts. (A) Motif enrichment analysis (Heinz et al. 2010) of the epiblast POU5F1 DamID-seq
peaks. (B) GO enrichment analysis of POU5F1 DamID-seq peaks from 7.5-dpc epiblasts using GREAT (McLean et al. 2010). (C) Differentially expressed
genes between ESCs and EpiSCs (Tesar et al. 2007). Red triangles represent the POU5F1 binding peak–associated genes in 7.5-dpc epiblasts. (D)
Expression levels of the 7.5-dpc epiblast POU5F1 binding peak–associated genes in ESCs and post-implantation epiblasts (Kojima et al. 2014). Genes whose
expression significantly changed 24 h after Pou5f1 deletion in the 7.5-dpc mouse embryo (DeVeale et al. 2013) are indicated in color. (CAV) Epiblast of
cavity; (PS) prestreak; (LMS) late mid streak; (LS) late streak; (OB) no bud; (EB) early bud; (LB) late-bud. (E,F) POU5F1 binding peaks identified by
DamID-seq (E) and expression changes of the development-related six genes upon Pou5f1 deletion in 7.5-dpc embryos (F) (DeVeale et al. 2013).
Mammalian DamID-seq with 1000 cells and in vivo
Genome Research 601
www.genome.org
 Cold Spring Harbor Laboratory Press on April 24, 2018 - Published by genome.cshlp.orgDownloaded from 
et al. 2011; Sexton et al. 2012), i.e., regions of the genome that are
not enriched for any specific histone modification and character-
ized by a low transcriptional output. Dam-POU5F1/SOX2 binding
signals in those regions might represent transient interactions of
POU5F1/SOX2 with the genome, and their functional importance
needs to be further investigated. Nevertheless, stronger POU5F1
DamID-seq peaks overlapped with the ChIP-seq peaks, as they
probably represent highly robust and/or frequent binding events.
Thus, selection of the strongest peaks among the total DamID
peaks may enable one to select the peaks likely detectable in
ChIP-seq. In summary, DamID-seq in mammalian cells represents
a novel powerful tool to reveal targets of TFs in yet-unexplored bi-
ological contexts.
Methods
Vector construction
The coding sequence of Damproteinwas taken from the pIND-V5-
EcoDam (gift from Prof. Bas van Steensel, NKI). TheNeo-Dam,Neo-
Dam-Pou5f1, Bsd-Dam, Bsd-Dam-Pou5f1, Hyg-Dam, and Hyg-Dam-
Pou5f1 pENTR vectors were generated by Gibson assembly
(Gibson et al. 2009). Two stop codons (TAA TAA) were added at
the end of each antibiotic-resistance gene, followed by a single C
base and the ATG codon of dam-only/dam-Pou5f1 (similar to the
system described by Southall et al. 2013). A 16-amino-acid residue
long linker (SGGGGSGGGGSGGGGS)was added between the dam
and the Pou5f1 coding region. Neo-Dam and Neo-Dam-Pou5f1
pENTR vectors were transferred into the pROSA26-DEST vector, af-
ter the PGK-Neo cassette was removed by in vitro Cre-loxP recom-
bination, via Gateway LR II Clonase (Invitrogen) recombination.
The dam∗ and dam∗-Pou5f1 (dam∗ =D181A mutant) sequences
were generated via site-directed mutagenesis and transferred into
a PB-CAG-pA-DEST (gift from Prof. Andras Nagy, Mount Sinai
Hospital) vector to generate CAG-Dam∗-IRES-Puromycin-pA and
CAG-Dam∗-Pou5f1-IRES-Puromycin-pA. All the plasmids are avail-
able upon request.
qDamID
gDNA was extracted from Dam-only/Dam-POU5F1 protein-ex-
pressing cells (about 1 × 106 to 2 × 106) using the DNeasy blood
and tissue kit (Qiagen) according to the manufacturer’s instruc-
tions. Extracted gDNA was treated overnight with and without
DpnII enzyme, diluted to a final concentration of 2 ng/µL, of
which 5 µL was used for each qPCR using the LightCycler480 in-
strument (Roche). The qPCR signal was converted to an absolute
numerical value based on a standard curve, and the average of
three triplicates from digested (+DpnII) and undigested (−DpnII)
gDNA was used to calculate the percentage (%) of methylation at
GATCX site in Dam-only or Dam-POU5F1 expressing cells:
%Dam−only or Dam−Pou5f1GATCX =
[Digested]
[Undigested] × 100.
This value was used to estimate the enrichment of Pou5f1 over
Dam (DamIDratioGATCX ), expressed as a subtraction:
DamIDsubtractGATCX =
%Pou5f1GATCx∑n
i %
Pou5f1
GATCi
− %
Dam
GATCx∑n
i %
Dam
GATCi
.
The primers used for the qDamID are listed in the Supplemental
Table S3.
DamID-seq
All the DamID-seq experiments were performed in a minimum of
three replicates for both Dam and Dam-POU5F1/SOX2. When us-
ing smaller number of cells (103), we performed the experiments in
four replicates. For the embryo data, we performed the experi-
ments in six embryos each for Dam-only and Dam-POU5F1.
For DamID-seq experiments on cell lines, the desired number
of cells were FAC-sorted using BD FACSAria II. When the number
of cells was above 10,000, cells were first spun down and then re-
suspended in the genomic lysis buffer provided in the Quick-
gDNAMicroPrep (ZymoResearch). When number of cells was low-
er than 10,000, cells were sorted directly into the genomic lysis
buffer. The gDNA was extracted according to the manufacturer’s
instructions and eluted with 10 µL of the elution buffer. The
gDNA was transferred into a 0.2-mL PCR tube containing 5 µL of
DpnI mix (20 units DpnI, 1× CutSmart buffer [NEB]) and digested
for 3 h at 37°C before heat inactivation of the enzyme for 20min at
80°C. Double-strand DamID adapters (Vogel et al. 2007) were pre-
pared by annealing AdRt (5′-CTAATACGACTCACTATAGGGCAG
CGTGGTCGCGGCCGAGGA-3′, IDT) and AdRb (5′-TCCTCGG
CCG-3′, IDT). Adapter ligation was performed by adding 5 µL of
ligation mix (20 units T4 ligase, 1× T4 ligase buffer [NEB], and
0.2 µM DamID adapters) to the 15 µL of DpnI-digested DNA solu-
tion and keeping overnight at 16°C. After heat inactivation of li-
gase for 20 min at 65°C, 5 µL of DpnII mix (10 unit of DpnII and
1× DpnII buffer [NEB]) was added, and the samples were kept for
1 h at 37°C before heat inactivation for 20 min at 65°C. Then,
100 µL of PCR mix (KAPA HiFi HS ReadyMix [KAPA Biosystems,
1×], 10 µM AdR PCR primer, 5′-GGTCGCGGCCGAGGATC-3′
[IDT], 1× SYBR green I nucleic acid gel stain [Life Technologies])
was added to the tube. From the final volume of 125 µL, 10 µL
was used to perform qPCR in technical duplicate (in total 20 µL),
and the number of PCR cycles to stop the PCR in the log-linear
amplification phase was determined. The remaining 105 µL was
then used to amplify the adapter-ligated fragments using the pro-
gram displayed in Table 1.
Samples were purified using SPRI magnetic beads, resuspend-
ed in 30 µL H2O and quantified by Qubit 2.0 (Invitrogen). The
sequencing libraries presented in this study have been prepared us-
ing the Nextera DNA sample preparation kit (Illumina), according
to the manufacturer’s instructions. Briefly, after Qubit quantifica-
tion, 50 ng of the PCR amplified DNA was used in a tagmentation
reaction (5min) in which the Tn5 enzyme fragments the DNA and
simultaneously inserts the preloaded Illumina adapters. After a
DNA purification step using the DNA clean and concentrator kit
(Zymo Research), the tagmented DNA was amplified by PCR for
five cycles using the program displayed in Table 2.
Primers used in the PCR amplification are barcoded, so a dif-
ferent pair of primers is used for each sample. After the PCR,DNA is
Table 1. PCR condition after adapter ligation
Temperature
(°C)
Time
(min) Cycles
72 10 1
94 1
165 5
72 15
94 1
465 1
72 10
94 1 (Determined by qPCR for
each sample)65 1
72 2
}
}
}
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purified using SPRImagnetic beads (0.8×DNAvolume) and eluted in
30 µL of water. The purified DNAwas used for Qubit 2.0 quantifica-
tion and Tapestation analysis before pooling of the libraries and sub-
mission to the sequencing facility. The concentration of the library
pool was usually ∼25–50 nM; 50-bp single-end sequencing was
performed at Edinburgh Genomics on the Illumina HiSeq 2500
(chemistry v. 4) systemor at BGI on the IlluminaHiSeq 4000 system.
A list of all the reagents and volumes required for each step of the
newly optimized DamID-seq protocol (from gDNA extraction to
next-generation library preparation) is summarized in Table 3.
DamID-seq data analysis
Accession numbers
POU5F1 DamID-seq data in ESCs used for the comparison in
Supplemental Figure S5 were downloaded from GEO with the
GEO accession number GSE64008.
Sequencing data quality
Read quality was visualized using charts generated by FastQC
(version 0.11.5) (http://www.bioinformatics.babraham.ac.uk/
projects/fastqc/), and these charts were aggregated and visualized
using MultiQC (version 0.9) (Ewels et al. 2016). The “per base se-
quence quality” chart showed reliable base calls across the entirety
of the reads; the “sequence length distribution” chart confirmed
that all our reads were of the same length; and the “sequence qual-
ity histogram” showed that the average quality per read was high
(Phred scores: 30–40). Nextera sequencing adapters were removed
using cutadapt and the relevant adapter sequence (version 1.13)
(Martin 2011).
Sequencing data alignment
The trimmed reads were aligned to the UCSC mm10 assembly of
the mouse genome (Church et al. 2009) using BWAMEM (version
0.7.15) (Li andDurbin 2010). For downstream analysis, we focused
on just primarymapped reads; unmapped, secondary, and supple-
mental alignments were filtered using SAMtools (version 1.4) (Li
et al. 2009). Reads mapped to uninformative (alternative, un-
placed, and mitochondrial contigs) or ENCODE blacklist regions
of the genome were also filtered using BEDTools (version 2.26.0)
(Quinlan and Hall 2010). For all DamID-seq data, PCR duplicates
were not removed.We reasoned that because readswere sequenced
from distinct genomic features (GATC fragments), the probability
of sequencing the same genomic region within a fragment would
be high, and thus, the number of PCR duplicates would be overes-
timated. This is conceptually similar to RNA-seq analysis, where
the probability of sequencing the exact same region from highly
abundant transcripts is high.
Peak calling analysis
To identify binding sites from DamID-seq data, we measure how
frequently each GATC fragment (windows along the genome en-
closed by a GATC sequence) is bound by the Dam-only and
Dam-POI proteins. Fragments that contain genuine binding sites
will be bound by the Dam-POI protein more often than the
Dam-only protein. Binding frequency is measured by sequencing
fragments that have beenmethylated by the Damprotein, and dif-
ferential binding is assessed by testing for significantly different
read counts for each fragment between the Dam-only and Dam-
POI samples.
Countmatrices were created by counting the number of reads
mapped fully within fragments, using the featureCounts com-
mand from Subread (version 1.5.0) (Liao et al. 2013). Low abun-
dance fragments that correspond to background regions were
subsequently removed to reduce the severity of the multiple test-
ing correction, increase detection power among the remaining
tests, and reduce computational load (Lun and Smyth 2016). An
arbitrary threshold of 10 read counts or lower in equivalent average
log-transformed counts per million (aveLogCPM) was used.
To address the high variability between DamID-seq replicates
(particularly from low cell numbers), we applied smooth quantile
normalization (Hicks et al. 2017). Unlike regular quantile normal-
ization, this method does not assume that the observed variability
in global properties are due only to technical reasons and are unre-
lated to the biology of interest (Hicks et al. 2017). The quantro
package (version 1.8.0) (Hicks and Irizarry 2015) was used to test
for global differences in the read count distributions between the
Dam-only and Dam-POI samples and thus objectively measure
the appropriateness of using smooth quantile normalization
over regular quantile normalization. Normalized count matrices
were created by generating logCPM values using the normalize
function from the csaw package (version 1.8.1) (Lun and Smyth
2016) and then applying smooth quantile normalization to the
logCPM values using the qsmooth package (version 0.0.1).
Differentially bound fragments were identified by testing
for differential abundance between the Dam-only and Dam-POI
Table 2. PCR condition after tagmentation
Temperature (°C) Time Cycles
72 3 min 1
98 10 sec } 563 30 sec72 3 min
Table 3. Summary of the DamID-seq protocol
Step Reagent used, company Mix volume Total volume of sample
gDNA extraction gDNA MicroPrep (Zymo Research) 10 µL 10 µL
DpnI digestion DpnI (NEB) 5 µL 15 µL
Adapter Ligation T4 ligase (NEB)
DamID adapters (IDT)
5 µL 20 µL
DpnII digestion DpnII, NEB 5 µL 25 µL
PCR amplification Kapa HiFi HS RM (Kapa Biosystems)
DamID PCR primers (IDT)
SYBR green (Life Technologies)
100 µL 125 µL
(10 µL ×2 for qPCR, 105 µL
for the sample amplification)
DNA amount Total volume of sample
Library
preparation
Nextera DNA library prep kit (Illumina) 50 ng 30 µL
Mammalian DamID-seq with 1000 cells and in vivo
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samples. The normalized countmatrices were given as input to the
limma-trend function from the limma package (3.30.13). The
trend and robust arguments were set to TRUE, fitting an intensity
dependent trend to prior variances and applying the robust empir-
ical Bayes procedure (Phipson et al. 2016). Differentially bound
fragments were then combined into differentially bound peak re-
gions using the mergeWindows and combineTests function from
the csaw package. The tol and max.width arguments were set to
260 (median GATC fragment size for the mm10 assembly) and
10,000, respectively. Peaks were defined as regions with a false-dis-
covery rate (FDR) smaller than 0.1 and a log fold-change (logFC)
>0.5. All of the above peak calling analysis was carried out using
the statistical programming language R (version 3.3.2) (R Core
Team 2013) and packages from the Bioconductor project (version
3.4) (Huber et al. 2015).
Read coverage visualization
Read coverage across the genomewas calculated with the genome-
cov command from BEDTools (version 2.26.0) (Quinlan and
Hall 2010). Coverage for each sample was scaled using the
normalization factors calculated in the peak calling analysis. The
bedGraph files were converted into bigWig files with the
UCSC bedGraphToBigWig (Kent et al. 2010) tool (version 4).
Subtracted bigWig files were generated using the diff command
from WiggleTools (version 1.2) (Zerbino et al. 2014).
Downstream analysis of peak calls
The intersection between different sets of peaks was calculated us-
ing the toolmergePeaks of the HOMER suite (version 4.8.3) (Heinz
et al. 2010). A proportional Venn diagram of three sets was gener-
ated using the software eulerAPE (version 3) (Micallef and Rodgers
2014), while proportional Venn diagrams of two sets were generat-
ed using the Venn diagram generator (http://jura.wi.mit.edu/bioc/
tools/venn.php). Box-plots and scatter plots were generated using
the package ggplot2 in the R statistical environment (version
3.3.2). The deepTools suite (Ramírez et al. 2016) was used to gen-
erate heatmaps using the computeMatrix and plotHeatmap
commands.
Data access
All DamID-seq data from this study have been submitted to the
Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/
geo/) under accession number GSE98092.
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